April 2026: Nationwide Recall of 3.1 Million Eye Drops; Levothyroxine Recall; Clindomycin, Alli Warnings; New Cholesterol Screening Guidelines; Thyroid Medications Regulation
Huge Recall of Children’s Ibuprofen, Apotex Eye Drops, Dangerous Dietary Supplements; Warnings for Levodopa, Xeljanz, Migraine Drugs, Sivextro, Children’s Xyzal; Antibiotics Research, Cancer Research
March 2026 Safety Update: Recalls for Metoprolol, Amantadine, Temozolomide, iKids Growth; Warnings for Paxlovid, Entyvio, Vabomere, Arthritis Pain Supplement
March 2026: Approvals for Promising Blood Cancer Treatment; Pediatric PKU Drug; Sinus Infections and Antibiotics; Health AI Tool Concerns; GLP-1 Pills Compared; Medication and Supplement Tips
Estradiol and Testosterone Recalls; Metoclopramide Warnings; Approvals for Pancreatic and Ovarian Cancer; Landmark PBM Reform; Pharma TV Commercials Flagged; Psychiatric Drugs and More
February 2026 Safety Update: Trazodone Recall; Urgent Recall for CGM Sensors; Non-Statin Pill Lowers LDL; Eye Drops for Presbyopia; Ozempic Tablet; Osteoporosis Drugs; SRI Safety Concerns, More
Pet Medication News: Recent Drug Approvals for Idiopathic Epilepsy and Lymphoma in Dogs; Minoxidil Warning; Largest-Ever Clinical Trial of Dogs Investigates Lifespan-Extending Treatment
January 2026: New or Expanded Approvals for: GLP-1 Weight Loss, Birth Control Implant, Lung Disease, Menkes, Gaucher; Omeprazole Research and Case Studies; Rx-OTC Switches; Medication Tips
January 2026: Recalls for Oxycodone, Wegovy, Rosuvastatin, Clearlife Nasal Spray; Blood Thinner Bleeding Antidote Withdrawn; Depo Provera, Addyi, and Hair Loss Drug News, More
